ArticleCancer immunology, immunotherapy : CII2023

Local immunotherapy with the RNA-based immune stimulator CV8102 induces substantial anti-tumor responses and enhances checkpoint inhibitor activity.

Johannes Lutz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.